Early identification of bacteremia by biochemical markers of systemic inflammation

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 61, Issue 7, 2001, Pages 523-530

  Rintala, E M ^a   Aittoniemi, J ^b   Laine, S ^b   Nevalainens, T J ^c   Nikoskelainen, J ^d  

^a SATAKUNTA CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TURKU UNIVERSITY   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

C reactive protein; Infection; Phospholipase A2; Procalcitonin; ROC analysis; Sensitivity; Sepsis; Specificity

Indexed keywords

BACTERIA (MICROORGANISMS);

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCITONIN; PHOSPHOLIPASE A; PROCALCITONIN; PROTEIN PRECURSOR;

ADULT; ARTICLE; BACTEREMIA; BLOOD; FEMALE; HUMAN; INFLAMMATION; MALE; METABOLISM; SENSITIVITY AND SPECIFICITY;

ADULT; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMAN; INFLAMMATION; MALE; MIDDLE AGE; PHOSPHOLIPASES A; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

EID: 0035232926     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655101753218283     Document Type: Article

References (30)

1. Young B, Gleeson M, Cripps A. C-reactive protein: a critical review. Pathology 1991; 23: 118-24.
2. Nevalainen T. Serum phospholipases A2 in inflammatory diseases. Clin Chem 1993; 39: 2453-9.
3. Rintala E, Pulkki K, Mertsola J, Nevalainen T, Nikoskelainen J. Endotoxin, interleukin-6 and phospholipase-A2 as markers of sepsis in patients with hematological malignancies. Scand J Infect Dis 1995; 27: 39-43.
4. Guidet B, Piot O, Masliah J, Barakett V, Maury E, Beretziat G, Offenstadt G. Secretory non-pancreatic phospholipase A2 in severe sepsis: relation to endotoxin. cytokines and thromboxane B2. Infection 1996; 24: 103-8.
5. Nyman K, Uhl W, Forsström J, Büchler M, Beger H, Nevalainen T. Serum phospholipase A2 in patients with multiple organ failure. J Surg Res 1996; 60: 7-14.
6. Hietaranta A, Kemppainen E, Puolakkainen P, Sainio V, Haapiainen R, Peuravuori H, Kivilaakso E, Nevalainen T. Extracellular phospholipase A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis. Pancreas 1999; 18: 385-91.
7. Nakae H, Endo S, Inada K, Yaegashi Y, Takakuwa T, Yamada Y, Arakawa N, Suzuki T, Taniguchi S, Shimamura T, Ogawa M, Teraoka H. Nitrate nitrite (NOX) and type II phospholipase A2. leukotriene B4, and platelet-activating factor levels in patients with septic shock. Res Commun Mol Pathol Pharmacol 1996; 92: 131-9.
8. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
9. Gendrel D, Raymond J, Assicot M, Moulin, F, Iniguez J-L, Lebon P, Bohuon C. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24: 1240-2.
10. Benador N, Siegrist C, Gendrel D, Greder C, Benador D, Assicot M, Bohuon C, Girardin E. Procalcitonin is a marker of seventy of renal lesions in pyelonephritis. Pediatrics 1998; 102: 1422-5.
11. Whang K, Steinwald P, White J, Nylen E, Snider R, Simon G, Goldberg R, Backer K. Serum procalcitonin precursors in sepsis and systemic inflammation. J Clin Endocrinol Metab 1998; 83: 3296-301.
12. Mimoz O, Benoist J, Edouard A, Assicot M, Bohuon C, Samii K, Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998; 24: 185-8.
13. Brunkhorst F, Eberhard O, Brunkhorst R. Discrimination of infectious and non-infectious causes of early acute respiratory distress syndrome by procalcitonin Crit Care Med 1999; 27: 2172-6.
14. De Werra I, Jaccard C, Corradin S, Chiolero R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner J-D, Glauser M, Heumann D. Cytokines. nitrite nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25: 607-13.
15. Schröder J, Staubach K-H, Zabel P, Stüber F, Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbeek's Arch Surg 1999; 384: 33-8.
16. Ugarte H, Silva E, Mercan D, De Mendonça A, Vincent J-L. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498-504.
17. ACCP SCCM Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
18. Bossink A, Groeneveld J, Koffeman G, Becker A. Prediction of shock in febrile medical patients with a clinical infection. Crit Care Med 2001; 29: 25-31.
19. Engel A, Steinbach G, Kern P, Kern W. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999; 31: 185-9.
20. Weinstein MP, Mirrett S, Relier LB, Comparative evaluation of Oxoid Signal and BACTEC radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol 1988; 26: 962-4.
21. Smith-Elekes S, Weinstein MP. Blood cultures. Infect Dis Clin North Am 1993; 7: 221-34.
22. Nevalainen T, Kortesuo P, Rinlala E, Märki F. Immunochemical detection of group I and group II phospholipase A2 in human serum. Clin Chem 1992; 38: 1824-9.
23. Dawson-Saunders B, Trapp R. Evaluating diagnostic procedures. In: Dawson-Saunders B, Trapp R, editors. Basic and clinical biostatistics. Norwalk, CT: Appleton & Lange; 1994. p. 232-48.
24. Weinrauch Y, Abad C, Liung NS, Lowry SF, Weiss J. Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group II phospholipase A2. J Clin Invest 1998; 102: 633-8.
25. Laine V, Grass D, Nevalainen T. Protection by group II phospholipase A2 against Staphylococcus aureus. J Immunol 1999; 162: 7402-8.
26. Rintala E, Nevalainen T. Synovial-type (group II) phospholipase A2 in serum of febrile patients with haematological malignancy. Eur J Haematol 1993; 50: 11-6.
27. Rintala E, Peuravuori H, Pulkki K, Voipio-Pulkki L-M, Nevalainen T. Bactericidal/permeability-increasing protein (BPI) in sepsis correlates with the severity of sepsis and outcome. Intensive Care Med 2000; 26: 1248-51.
28. Oczenski W, Fitzgerald R, Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period. Eur J Anaesthesiol 1998; 15: 202-9.
29. Oberhoffer M, Karzai W, Meier-Hellmann A, Bögel D, Fassbinder J, Reinhart K. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-x and interleukin-6 in patients with sepsis. Crit Care Med 1999; 27: 1814-8.
30. Uhl W, Beger HG, Hoffmann G, Hanisch E, Schild A, Waydhas C, Entholzner E, Muller K, Kellermann W, Vogeser M, Leskopf W, Zügel M, Bucsh EW, Büchler MW. A multicenter study of phospholipase A2 in patients in intensive care units. J Am Coll Surg 1995; 180: 323-31.